Recent Event Highlights: In Shakeup, NJ Appoints New Health Care Prosecutor - Main Justice, Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence - Pharmaceutical Online (press release), Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence - PR Newswire (press release), U.S. Supreme Court Affirms Lower Court Decision on Merck Federal Securities ... - MarketWatch (press release), Merck & Co. Inc: PharmaVitae Profile - new market report released - PR-inside.com (press release), Merck Provides Information on Impact of U.S. Health Care Reform Legislation - MarketWatch (press release), and 38 more...
Created by dipity on Mar 9, 2009
Last updated: 09/13/10 at 10:44 AM
Merck Schering Plough Merger has no followers yet. Be the first one to follow.
MiamiHerald.comMerck, Summit's largest taxpayer, adds employees to siteNJ.comEight years ago Schering Plough purchased the property until the latest merger. Glatt noted there had been some speculation whether Merck would close the ...Merck Announces Senior Management AppointmentsMarketWatch (press release)Merck & Co makes management changesTrading Markets (press release)Merck Promotes Frazier to President, Second to CEOBusinessWeekForbes (blog) -NASDAQ -Zacks.comall 137 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.nj.com%2Findependentpress%2Findex.ssf%2F2010%2F04%2Fmerck_summits_largest_taxpayer.html&usg=AFQjCNFm3SerGVEstyAsIpR9KVRQtLUfGw
Main JusticeIn Shakeup, NJ Appoints New Health Care ProsecutorMain JusticeShe served as co-lead counsel to Schering Plough in defending against shareholder lawsuits challenging its merger with Merck. She also represented Bristol ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.mainjustice.com%2F2010%2F04%2F29%2Fin-shakeup-n-j-appoints-new-health-care-prosecutor%2F&usg=AFQjCNET49akfbzxaY5Sx6NCYrx_THovFw
Bio-Pharma Industry Experts Deliver M&A Value Through Integration ExcellencePharmaceutical Online (press release)Chapel Hill, NC/PRNewswire/ - The biopharma mega-mergers that grabbed headlines last year - Roche + Genentech, Pfizer + Wyeth and Merck + Schering-Plough ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBio-Pharma-Industry-Experts-Deliver-MA-Value-0001&usg=AFQjCNH_ZyxH2kaaQN99OI8UGhSzyPON4w
Bio-Pharma Industry Experts Deliver M&A Value Through Integration ExcellencePR Newswire (press release)... NC, April 28 /PRNewswire/ -- The biopharma mega-mergers that grabbed headlines last year - Roche + Genentech, Pfizer + Wyeth and Merck + Schering-Plough ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbio-pharma-industry-experts-deliver-ma-value-through-integration-excellence-92318919.html&usg=AFQjCNFjveKDkHb0O_W2WFwqPbEoYVLoHA
Biotech Has First Profitable Year After Research Spending CutsBusinessWeeks November purchase of Schering-Plough Corp. for $51 billion. “You have fewer potential buyers, and those companies themselves -- from a post-merger ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.businessweek.com%2Fnews%2F2010-04-28%2Fbiotech-has-first-profitable-year-after-research-spending-cuts.html&usg=AFQjCNHTUKWefKKWiUEFUNWEcqvUY8jLtw
MCS Healthcare Public Relations launches communications training with JMB ...myCentralJersy.comIn her most recent role as vice president of investor relations at Schering-Plough, she led the company's global investor relations program and partnered ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.mycentraljersey.com%2Farticle%2F20100428%2FBUSINESS%2F100427043%2F-1%2Fnewsfront%2FMCS-Healthcare-Public-Relations-launches-communications-training-with-JMB-Consulting&usg=AFQjCNEkCpW_Knjpa_wRmM-1opIf5TcYXA
U.S. Supreme Court Affirms Lower Court Decision on Merck Federal Securities ...MarketWatch (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fus-supreme-court-affirms-lower-court-decision-on-merck-federal-securities-class-action-2010-04-27%3Freflink%3DMW_news_stmp&usg=AFQjCNGXjogbLX9LZDSexWE9O7gxR_Opvg
Merck & Co. Inc: PharmaVitae Profile - new market report releasedPR-inside.com (press release)*Assess the strategic implications of Merck & Co.´s recently announced merger with Schering-Plough *Analyze the impact of generic erosion across key Merck ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.pr-inside.com%2Fmerck-co-inc-pharmavitae-profile-r1852136.htm&usg=AFQjCNEVOPdysutl1DzkYgSPFVOLwWlkww
TopNews United StatesMerck Provides Information on Impact of U.S. Health Care Reform LegislationMarketWatch (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...Merck health-reform costs below rivals, shares jumpReutersMerck Fears Drop in Revenue Due to Healthcare ReformsTopNews United Statesall 215 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fmerck-provides-information-on-impact-of-us-health-care-reform-legislation-2010-04-23%3Freflink%3DMW_news_stmp&usg=AFQjCNHJtGVleDMxiQUALKBRinex3vw4Dw
BNETMerck's Munificence: Ex-Schering CEO Fred Hassan Walks Away With $50MBNETThe merger of Merck (MRK) and Schering-Plough cost 17500 employees their jobs — but management made out like bandits. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Findustry.bnet.com%2Fpharma%2F10007664%2Fmercks-munificence-50m-payouts-for-ousted-execs-cfo-got-500k-to-move-house%2F&usg=AFQjCNGBUfvkZq8-fLTNe3-wytZWOyYNpA
ZEGERID OTC Hits Store Shelves; Offers Only Patented Dual-Ingredient Option ...Advertiser TalkSuch statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.advertisertalk.com%2Fzegerid-otc-hits-store-shelves-offers-only-patented-dual-ingredient-option-for-24-hour-frequent-heartburn-relief-without-a-prescription-11976.zhtml&usg=AFQjCNH1grqLVqh0grpJhZqEQr6tJR8KzQ
We GOT You to the Tune of ... Zero: Judge OKs Zero-Dollar SettlementCorporate CounselAll the suits were eventually consolidated in federal court in Newark under the caption In re Schering-Plough/Merck Merger Litigation, 09-cv-1099. ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.law.com%2Fjsp%2Fcc%2FPubArticleCC.jsp%3Fid%3D1202447275229%26We_GOT_You_to_the_Tune_of__Zero_Judge_OKs_ZeroDollar_Settlement&usg=AFQjCNEZ8pUa43XzAOdO9QzldGbJvZBRtw
ZEGERID OTC(TM) Hits Store Shelves; Offers Only Patented Dual-Ingredient ...PR Newswire (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fzegerid-otctm-hits-store-shelves-offers-only-patented-dual-ingredient-option-for-24-hour-frequent-heartburn-relief-without-a-prescription-89677327.html&usg=AFQjCNGJJNUpeqwuJkQd42gJbQUAuMRMAg
All quiet on major deal front for drugmakersReuters"As they get closer to the (patent) cliff, then their fate will likely be similar to what happened with Pfizer/Wyeth and with Merck and Schering-Plough," ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSTRE62P3H120100326&usg=AFQjCNHFPZGVtpkBoFbtV1kImTpurVDYtw
Bayer still out to buy, not sell, vet businessesReuters... up animal health businesses that were offered as part of Wyeth's merger with Pfizer (PFE.N) and the tie-up between Merck & Co and Schering-Plough. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSTRE62P1E320100326&usg=AFQjCNFlgzXqfQE6weDkZA_enoVcODIWUw
Ten-Year Data on Pharmaceutical Mergers and Acquisitions, from ...MarketWatch (press release)... and Abbott Laboratories' acquisition of Solvay Pharmaceuticals, 2009 saw Merck & Co.'s acquisition of Schering-Plough Corporation for $41.1 billion. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Ften-year-data-on-pharmaceutical-mergers-and-acquisitions-from-dealsearchonlinecom-reveals-top-deals-and-key-companies-2010-03-25%3Freflink%3DMW_news_stmp&usg=AFQjCNHWEPuf-qgEhYT92sT-zpLzx2CKuQ
New B+L leadership ready to 'power up'RocNowAt Schering-Plough, he was president of the global consumer health care division. And he was named head of integration for the Merck merger. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Frocnow.com%2Farticle%2Fbusiness%2F20103210332&usg=AFQjCNGmNiisWT3-K94BhCDwmmUTxCI59A
Latest featureHays PharmaIn November, it was the turn of Merck and Schering-Plough, which completed their $41 billion merger deal, debuting as one company. ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.hayspharma.com%2Fnews%2Fclinical-research%2Fpharmaceutical-mergers-could-accelerate-research%2F19260622&usg=AFQjCNF6ttVKJmXgGBhLaqu6KxoCjYkNww
US animal health merger would create global giantStock and LandThe merger will take the form of sanofi-aventis' acquisition of Intervet/Schering-Plough for $1 billion in an initial payment of $250 million and an ...Pharmaceutical Profits That Aren't For The DogsInvestopediaall 8 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fsl.farmonline.com.au%2Fnews%2Fnationalrural%2Fagribusiness-and-general%2Fpolitical%2Fus-animal-health-merger-would-create-global-giant%2F1776155.aspx&usg=AFQjCNGaPH12bLAmDsMUfIiuTuS0j-hsjQ
The Star-Ledger - NJ.comMerck And GTx Go Their Separate WaysForbes... and profitable company, says CEO Mitchell Steiner as the drug trials have faced significant delays during Merck's recent merger with Schering-Plough. ...GTx, Merck Part WaysMemphis Daily Newsall 41 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.forbes.com%2F2010%2F03%2F15%2Fgtx-merck-pharma-markets-equities-drug-trial.html%3Fboxes%3Dmarketschannelnews&usg=AFQjCNH99BqcvMrkMXQ7AS2IUU9qxlnY3g
The Star-Ledger - NJ.comEx-Schering chiefs join up at BauschFiercePharmaEveryone was watching to see where ex-Schering-Plough chief Fred Hassan (photo) would land after the big Merck merger put him out of a job. ...Bausch & Lomb taps Schering-Plough execs as chairman, CEOPRWeekBausch + Lomb names new board chairman, CEOOSN SuperSiteBausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive ...PR-USA.net (press release)The Star-Ledger - NJ.com -Rochester Democrat and Chronicleall 146 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fex-schering-chiefs-join-bausch%2F2010-03-15&usg=AFQjCNFbEpdSLXz38vRJnx1LYNswg2ApcQ
Forbes (blog)Fred Hassan's New JobForbes (blog)Hassan specializes in cleanup jobs like this, having righted Pharmacia after a bad merger and moved Schering-Plough through negotiations with the US ...Bausch and Lomb appoints new chairman and CEOZenopaall 3 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fblogs.forbes.com%2Fsciencebiz%2F2010%2F03%2Ffred-hassans-new-job%2F&usg=AFQjCNHmPBGLHgYnHSMgJxQBtVV_btEyMw
Portola Pharmaceuticals and Merck Announce that Phase 2 Study Showed ...MarketWatch (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fportola-pharmaceuticals-and-merck-announce-that-phase-2-study-showed-investigational-factor-xa-inhibitor-betrixaban-reduced-incidence-of-bleeding-compared-to-warfarin-in-patients-with-atrial-2010-03-15%3Freflink%3DMW_news_stmp&usg=AFQjCNGFq5apjvR5gTUY1hAO42tZo9ZdEg
Boston GlobeWeil, Howrey Helping Merck, Sanofi Through Strange Antitrust DanceThe American LawyerIt started one year ago today, when Merck and Schering-Plough agreed to combine in a massive $41 billion deal in the red hot pharma sector. ...Merial to merge with Intervet/Schering-PloughZenopaMerck & Co. Announced Merger with Sanofi-Aventis SATransWorldNews (press release)Sonofi-Merck (MRK) Deal PositiveBenzingaGulfNews -Montreal Gazetteall 390 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Famlawdaily.typepad.com%2Famlawdaily%2F2010%2F03%2Fmercksanofi.html&usg=AFQjCNGuBru-cITvtEQTOeR8Gt0oqBwVdA
Merck Statement on Vioxx(R) Judgment in AustraliaMarketWatch (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fmerck-statement-on-vioxxr-judgment-in-australia-2010-03-04%3Freflink%3DMW_news_stmp&usg=AFQjCNHqub3_v5Pw92TEAhZPSAHwXBv20w
Merck updates pipeline with Schering additionsFierceBiotechFollowing its acquisition of Schering-Plough, Merck has released an updated pipeline that features 20 candidates in Phase III or under regulatory review, ...Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and ...MarketWatch (press release)New Merck trumpets streamlined 'best in industry' pipelinePharma TimesINTERVIEW-Merck research chief touts insomnia drug, pipelineAlibaba News Channelall 268 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Fmerck-updates-pipeline-schering-additions%2F2010-03-01&usg=AFQjCNGw8A0ovuiKmZFp4Nkej7l9wrMMvA
AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership ProductsMarketWatch (press release)Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fastrazeneca-exercises-option-to-acquire-mercks-interest-in-partnership-products-2010-03-01%3Freflink%3DMW_news_stmp&usg=AFQjCNEVt7uuoJIMJ0zXxBkdc7mcNAAjwQ
Fred is laughing all the way to the bank after he sold Schering Plough out. You greedy fuck!!!
Register now @meettheboss.tv to view the full interview bit.ly In 2003, when Fred Hassan took over as chiefexecutive at Schering-Plough, the company was in freefall and being investigated for accounting irregularities. In 2008 he lead the company to netprofits of over $18.4 billion. And in 2009, he successfully oversaw the $41.1billion mega-merger with Merck. Incredible challenges; incredible turnaround. In this interview, you will find out: How to lead through the layers ofyour organization How to start a company turnaround How to get energy and alignment in your frontlineteam
Merck Merger Wins FTC Approval October 30, 2009, 6:27 am Merck and Schering-Plough said Thursday they have won merger approval from the Federal Trade Commission and antitrust regulators in Switzerland and Canada. Merck hopes to close its $41.1 billion acquisition of Schering-Plough before the end of the year. The companies said that the FTC and Canadian Competition Bureau ended their waiting periods to review the transaction. European regulators cleared the deal this month, but its still under review in China and Mexico, The Associated Press said. The deal would create the worlds second-largest producer of prescription medicines, with about $42 billion in annual sales. That would place it behind only Pfizer Inc., which this month bought Wyeth for $68 billion. As a condition of of the ftcs consent, Merck must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis, and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting. Merck and Schering-Plough shareholders approved the sale in August. Shares of Merck fell 74 cents, or 2.3 percent, to close regular trading at $31.31. Schering-Plough shares lost 31 cents to finish at $28.43.
Excerpt
...YORK - Merck & Co and Schering-Plough Corp said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. This undated handout image, provided by Merck & Co. Inc....
Source Info
International Business Times
http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm
Excerpt
...set forth in the forward-looking statements: the possibility that the expected synergies from the proposed merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period, due to, among other things, the impact...
Source Info
Drugs.com
http://feeds.drugs.com/~r/Drugscom-HeadlineNews/~3/pF6_SuEXpgQ/merck-schering-plough-receive-approval-european-commission-merger-20519.html
Excerpt
...but they still need approval from the U.S. Federal Trade Commission. The deal is structured as a reverse merger, with Schering-Plough technically acquiring Merck but the better-known Merck name surviving. That was done to try to preserve roughly $2 billion...
Source Info
NorthJersey.com
http://www.northjersey.com/r?19=961&43=515652&44=60013782&32=4497&7=309037&40=http%3A%2F%2Fwww.northjersey.com%2Fnews%2Fbusiness%2FMerck_seeks_EU_approval_to_buy_Schering-Plough_.html
- today President Obama signed into law an extension for the "cash for clunkers" program - you still have time for car shopping and at a special meeting this morning, shareholders of drugmakers Merck and Schering-Plough overwhelmingly backed a merger of the two companies - which would make the new company second largest in the world. ... AIG "Magna International" "Royal Bank of Scotland" RBS "CIT Group" CIT Investors unemployment "President Obama" "Cash of Clunkers" Merck Schering-Plough ...
Excerpt
...No. 2 worldwide, just behind Pfizer Inc. The new Merck would have about $42.4 billion in annual sales. Shareholders of Schering-Plough will vote on the merger this afternoon at a special meeting in Boston. The two companies still need approval from the Federal...
Source Info
KansasCity.com
http://www.kansascity.com/438/story/1369899.html
Excerpt
...Merck's chairman Richard Clark said the deal "should enable us to proceed expeditiously with the closing of our merger with Schering-Plough in the fourth quarter as planned." Federal health regulators said Tuesday an experimental psychiatric drug from Schering-Plough...
Source Info
Pakistan News.net
http://feeds.pakistannews.net/?rid=26812363&cat=2411cd3571b4f088
Drugmakers Merck & Co. and Schering-Plough Corp. said today they will pay $5.4 million to settle a multistate investigation that the companies delayed the release of test results casting doubt on the effectiveness of two blockbuster cholesterol drugs, violating consumer protection laws. Investors used good news from Intel and the Fed as a reason to rush back into stocks. Strong earnings and an upbeat forecast from Intel Corp. pulled investors into the stock market today as hopes grew that the economy could be starting to recover. The chip maker's results signal that computer sales are picking up faster than had been expected. Amazon.com has been sued by a user of its Kindle electronic reader who claims the device's cover, which is sold separately, can break the screen and make the device inoperable. The lawsuit, filed yesterday, claims that the covers designed and sold by Amazon to protect the device often end up cracking the Kindle screens due to pressure on the hinge. US regulators filed civil charges today, involving two separate trading rings, for insider trading against 11 people, including a 26-year-old former Goldman Sachs investment banking analyst accused of leaking confidential merger information to his brother. The median housing price increased in both Riverside and San Bernardino counties in June, after about 30 months of steady declines in home values. The median sales price in Riverside County rose to $185000 from $180000 a month earlier. While in San ...
Excerpt
...It is expected to close in the fourth quarter. "Under the plain reading of (the change-in control) provision, Merck and Schering-Plough believe that completion of the merger will not entitle Centocor to terminate the distribution agreement," the proxies state....
Source Info
Miami Herald
http://www.miamiherald.com/business/breaking-news/story/1099454.html
Excerpt
...fourth quarter. The deal is structured as a reverse merger that will make Schering the surviving company, but keep Merck's name - an attempt to preserve about $2 billion a year in revenue Schering-Plough gets through a partnership with Johnson & Johnson on...
Source Info
The Seattle Times
http://seattletimes.nwsource.com/html/businesstechnology/2009096060_apusearnsdrugs.html?syndication=rss
Katie McQue reports that two major companies will merge as Merck is said to be buying Schering-Plough in a 41 billion dollar deal in an effort to boast its development pipeline. For scripnews.com
Excerpt
...company also has a licensing and collaboration deal with Anacor Pharmaceuticals, headquartered in Palo Alto. The Merck-Schering Plough deal comes only a few weeks after Lipitor maker Pfizer Inc. agreed to pay $68 billion for drugmaker Wyeth. The deal would...
Source Info
San Francisco Chronicle
http://feeds.sfgate.com/click.phdo?i=01d155ab299531c278230ba62e61d113
American Oriental Bioengineering, HSBC, Aastrom Biosciences, Geron, StemCells, plus merger to watch: Merck/Schering-Plough. ... CBOE CBOE-TV CBOETV Doctor Jon Najarian Angela Miles Angie In The Money Before the Bell Options stock market finance options Dan Sheridan Safari Chicago board exchange
Excerpt
...the hepatitis C treatment boceprevir. Schering shareholders will get $10.50 in cash and 0.5767 Merck shares for each Schering-Plough share they own. The deal is being structured as an unusual reverse merger, in which the surviving corporation will be Schering-Plough,...
Source Info
Business Week
http://www.businessweek.com/bwdaily/dnflash/content/mar2009/db2009039_430130.htm?campaign_id=rss_daily
Excerpt
...and bid for Schering-Plough? The fit between the two companies is as good as -- if not better -- than the fit between Schering-Plough/Merck.' On a call with investors early Monday, Clark said that because the deal was a reverse merger, Schering-Plough's rights...
Source Info
MarketWatch
http://www.marketwatch.com/enf/rss.asp?guid=%7B870A9DE6-E22F-415D-8C9B-60C1CA97FC06%7D&siteid=rss&rss=1
Ledger Live for Monday March 9th, 2009 - Ledger Live with Brian Donohue. On today's show: Two giant New Jersey drug makers, Merck and Schering-Plough announce mergers. And we turn the video cams on East Amwell homeowner Mike Strizki, who uses hydrogen and solar power to make his home not just energy efficient, but energy-producing.
An interview with Michael Obuchoski, CIO of first Empire Asset Management with his thoughts and opinion between Merck and Schering-Plough merger. (Morning Call)
Excerpt
...suntan line and Dr. Scholl's foot products. The transaction is to be structured as a reverse merger. As a result, Schering-Plough will be the surviving corporation but will be take the name Merck. The new company will stay at Merck's headquarters in Whitehouse...
Source Info
Centre Daily Times
http://www.centredaily.com/business/story/1159596.html
Excerpt
...while creating meaningful value for shareholders.” The transaction will be structured as a “reverse merger” in which Schering-Plough, renamed Merck, will continue as the surviving public corporation. Merck said it expected annual cost savings of about $3.5...
Source Info
The New York Times
http://feeds.nytimes.com/click.phdo?i=faec0375621b72fbea01508b7c2dcb0f
Excerpt
...suntan line and Dr. Scholl's foot products. The transaction is to be structured as a reverse merger. As a result, Schering-Plough will be the surviving corporation but will be take the name Merck. The new company will stay at Merck's headquarters in Whitehouse...
Source Info
CBS 5
http://cbs5.com/business/merck.schering.plough.2.953538.html
Excerpt
...suntan line and Dr. Scholl's foot products. The transaction is to be structured as a reverse merger. As a result, Schering-Plough will be the surviving corporation but will be take the name Merck. The new company will stay at Merck's headquarters in Whitehouse...
Source Info
Toronto Star
http://www.thestar.com/article/598836
Update Sources